Patent details

LUC00101 Product Name: Encorafenib sous toutes ses formes telles que protégées par le brevet de base

Basic Information

Publication number:
LUC00101
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP107482119
Legal Status:
Inactive
Application number:
LUC00101
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1314
Marketing Authorization Type:
Marketing Authorization Date:
24/09/2018
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
12/02/2019
First Marketing Authorization date:
24/09/2018
Grant date:
23/01/2020
Activation date:
Publication date:
13/02/2019
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
24/09/2033
SPC Extension Expiration:
24/09/2033
Rejection date:
Withdrawal date:

Owner

From:
31/05/2021
 
 

Name:
Array BioPharma Inc.
Address:
3200 Walnut Street, Boulder, CO 80301, United States (US)

History of Owners

From:
12/02/2019
To:
31/05/2021

Name:
Array BioPharma Inc.
Address:
3200 Walnut Street, Boulder, CO 80301, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
12/02/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2019/04
Publication date:
11/03/2019
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2020/03
Publication date:
10/02/2020
Description:
Section D : Granted supplementary protection certificates – I2 publication

3

Bulletin Heading:
CO
Bulletin edition number:
2021/07
Publication date:
03/06/2021
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20210000208B
Date Registered:
31/05/2021
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
fusion-absorption
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Array BioPharma Inc.
Address:
3200 Walnut Street, Boulder, CO 80301, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
02/09/2030
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
12/02/2019 Application Form 8
12/02/2019 General Document 50
13/02/2019 Publication 1
12/02/2019 General Document 3
23/01/2020 Certificate 1
31/05/2021 Request For Change 9
31/05/2021 Outgoing Correspondence 2
12/02/2019 General Document 4
13/02/2019 Outgoing Correspondence 1
23/01/2020 Outgoing Correspondence 1
23/01/2020 Publication 1